Twist Bioscience Corporation Common Stock (TWST)

Health Care – BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Headquarters
United States
Employees
979
Market Cap
$5.7B

About Twist Bioscience Corporation Common Stock

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Twist Bioscience Corporation Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.